ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
67,088.80
0.01%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Minerva Neurosciences Inc (NERV)

  7. Minerva Neurosciences Inc (NERV) Noticias

NERV

Minerva Neurosciences (NERV)

Minerva Neurosciences Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:NERV
FechaHoraFuenteTítuloSímboloCompañía
01/05/202406:30GlobeNewswire Inc.Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business UpdatesNASDAQ:NERVMinerva Neurosciences Inc
27/02/202407:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NERVMinerva Neurosciences Inc
27/02/202407:00GlobeNewswire Inc.Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with SchizophreniaNASDAQ:NERVMinerva Neurosciences Inc
22/02/202406:00GlobeNewswire Inc.Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business UpdatesNASDAQ:NERVMinerva Neurosciences Inc
22/02/202405:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NERVMinerva Neurosciences Inc
07/11/202306:30GlobeNewswire Inc.Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business UpdatesNASDAQ:NERVMinerva Neurosciences Inc
07/11/202306:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NERVMinerva Neurosciences Inc
05/10/202315:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NERVMinerva Neurosciences Inc
15/08/202308:28Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:NERVMinerva Neurosciences Inc
15/08/202308:26Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NERVMinerva Neurosciences Inc
15/08/202308:25Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:NERVMinerva Neurosciences Inc
09/08/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NERVMinerva Neurosciences Inc
09/08/202316:12Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:NERVMinerva Neurosciences Inc
04/08/202307:07Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:NERVMinerva Neurosciences Inc
01/08/202306:30GlobeNewswire Inc.Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business UpdatesNASDAQ:NERVMinerva Neurosciences Inc
07/07/202315:18Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:NERVMinerva Neurosciences Inc
03/07/202315:04Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:NERVMinerva Neurosciences Inc
28/06/202307:38Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NERVMinerva Neurosciences Inc
28/06/202307:30GlobeNewswire Inc.Minerva Neurosciences Announces $20 Million in Private Placement Priced at a Premium to MarketNASDAQ:NERVMinerva Neurosciences Inc
15/05/202306:30GlobeNewswire Inc.Minerva Neurosciences Reports 2023 First Quarter Financial Results and Business UpdatesNASDAQ:NERVMinerva Neurosciences Inc
15/05/202306:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NERVMinerva Neurosciences Inc
10/05/202307:00GlobeNewswire Inc.Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in SchizophreniaNASDAQ:NERVMinerva Neurosciences Inc
08/05/202307:30GlobeNewswire Inc.Minerva Neurosciences to Report First Quarter 2023 Financial Results and Business Updates on May 15, 2023NASDAQ:NERVMinerva Neurosciences Inc
02/05/202317:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NERVMinerva Neurosciences Inc
01/05/202306:00GlobeNewswire Inc.Minerva Neurosciences Announces the NDA Filing for Roluperidone for the Treatment of Negative Symptoms in SchizophreniaNASDAQ:NERVMinerva Neurosciences Inc
08/03/202306:30GlobeNewswire Inc.Minerva Neurosciences Reports Fiscal Year 2022 Fourth Quarter And Year End Financial Results And Business UpdatesNASDAQ:NERVMinerva Neurosciences Inc
01/03/202307:30GlobeNewswire Inc.Minerva Neurosciences to Report Fiscal Year 2022 Financial Results and Business Updates on March 8, 2023NASDAQ:NERVMinerva Neurosciences Inc
14/02/202315:14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NERVMinerva Neurosciences Inc
10/11/202205:16TipRanksMinerva Neurosciences (NERV) Receives a Buy from BTIGNASDAQ:NERVMinerva Neurosciences Inc
09/11/202211:30TipRanksAnalysts Offer Insights on Healthcare Companies: GlycoMimetics (GLYC) and Minerva Neurosciences (NERV)NASDAQ:NERVMinerva Neurosciences Inc
 Showing the most relevant articles for your search:NASDAQ:NERV

Su Consulta Reciente

LSE
SI26
Barclays 26
UNSW3
KIZUNAETH
KIZUNA
USOTC
CBMDF
CBM Asia Developmental (CE)
LSE
85RW
Investec Bnk 25
NASDAQ
FSUVRX
American Agenda Portfoli...
NASDAQ
FYJSKX
Virtual Economy Portfoli...
COIN
DESSUST
DeSpace Protocol
LSE
80OL
BIT
P21DR7
NLBNPIT21DR7 20240920 38...
LSE
MHG
Merchant House
BIT
GM
Gentili Mosconi
NASDAQ
PPCAX
Principal Private Credit...
COIN
DTCTBTC
NASDAQ
KMPH
KemPharm
BITMOT
617366
Eib Nv26 Zc Eur
BMF
WDOQ24
WDOQ24 - Agosto 2024
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados